NXT-10796
NXT-10796 is orally active, intestinally restricted EP4 receptor agonist[1].
Product Specifications
UNSPSC
12352005
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nxt-10796.html
Solubility
10 mM in DMSO
Smiles
O=C(NNC(C(O)=O)=O)CCCCCCN1[C@@H](/C=C/[C@@H](O)CC2=CC=CC=C2)CCC1=O
Molecular Formula
C23H31N3O6
Molecular Weight
445.51
References & Citations
[1]St-Onge M, et al. Discovery of NXT-10796, an orally active, intestinally restricted EP4 agonist prodrug for the treatment of inflammatory bowel disease. Bioorg Med Chem Lett. 2023;91:129351.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1464403 1.0 µg DNA
NUDT4P1 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
